{"symbol":"BSX","fiscalQuarter":"Q4-2017","reportDate":"2018-02-01","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2017","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Down 1.18%","keyNumbers":[{"metric":"EPS","actual":"$0.34","expected":"N/A","surprise":"-3.11%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing investments in innovation.","They acknowledged challenges in the market but expressed confidence in long-term growth."],"summary":"Overall, management conveyed a cautious optimism about future opportunities despite current market challenges. They emphasized their commitment to innovation and growth."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report indicates a slight miss on EPS, which contributed to a 1.18% decline in stock price. The company did not provide revenue figures or future guidance, leaving investors with limited insights into its financial outlook. Management's cautious tone suggests they are aware of market challenges but remain focused on long-term growth strategies.","metaDescription":"Boston Scientific (BSX) Q4 2017 earnings: EPS missed expectations. Stock down 1.18%. Full breakdown."}}